ScreenerHero

SEER Seer, Inc.

NAS · US · Healthcare · Biotechnology · seer.bio
2.210USD+0.91%Mkt Cap: 122.37M $P/E: —

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap122.37M USD
Enterprise Value-9.20M USD
Revenue (TTM)14.22M USD
Gross Profit8.01M USD
Net Income (TTM)-73.60M USD
Revenue/Share0.25 USD
Last Price2.210 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees124
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.15
PEG—
EV/EBITDA0.14
EV/Revenue-0.65
P/S8.53
P/B0.54
EPS (TTM)-1.14
EPS (Forward)-1.02
52W Range
1.55077% of range2.410
52W High2.410 USD
52W Low1.550 USD
Profitability
Gross Margin49.67%
Oper. Margin-542.91%
EBITDA Margin0.00%
Profit Margin-456.60%
ROE-28.38%
ROA-24.86%
Growth
Revenue Growth-23.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.45M USD
CapEx (TTM)1.80M USD
FCF Margin-188.49%
FCF Yield-21.90%
Net Debt-130.46M USD
Net Debt/EBITDA2.01
Balance Sheet
Debt/Equity0.09
Current Ratio14.74
Quick Ratio13.87
Book Value/Sh4.08 USD
Cash/Share2.76 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.000 USD
Upside (mean)+81.0%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.55.37M
Float40.53M
Insiders14.65%
Institutions50.79%
Short Interest
Short Ratio0.5d
Short % Float0.18%
Short % Out.0.16%
Shares Short87.33K
Short (prev mo.)123.03K
Technical
SMA 502.037 (+8.5%)
SMA 2001.903 (+16.1%)
Beta1.47
S&P 52W Chg16.45%
Avg Vol (30d)270.24K
Avg Vol (10d)437.76K
Technical Indicators
RSI (14)60.5
MACD0.0628
MACD Signal0.0264
MACD Hist.+0.0364
BB Upper2.345 USD
BB Middle2.021 USD
BB Lower1.697 USD
BB Width32.02%
ATR (14)0.0976 USD
Vol Ratio (20d)0.86x